The Precision Health Initiative is conducted by Genuity Science. Listen to our new podcast here.

Accelerating the Translation of Genomic Insight to Therapeutics

Last month, Genuity Science announced a multiyear collaboration with Ionis Pharmaceuticals aimed at accelerating this transition from target to therapeutic in multiple disease areas. GEN caught up with Leo Sahelijo, MD, vp of translational medicine at Ionis, and Jeffrey Gulcher, MD, PhD, chief scientific officer at Genuity to discuss the collaboration.

Read the article.